LSD1/HDAC6-IN-1 |
Catalog No.GC62434 |
LSD1/HDAC6-IN-1은 항종양 활성이 있는 라이신 특이적 데메틸라제 1(LSD1)/히스톤 데아세틸라제 6(HDAC6)의 경구 활성 이중 억제제입니다. LSD1/HDAC6-IN-1은 다발성 골수종(MM) 연구에 사용할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2738306-38-0
Sample solution is provided at 25 µL, 10mM.
LSD1/HDAC6-IN-1 is an orally active dual inhibitor of lysine specific demethylase 1(LSD1)/Histone deacetylase 6 (HDAC6), with anti-tumor activity. LSD1/HDAC6-IN-1 can be used for the research of multiple myeloma (MM)[1].
LSD1/HDAC6-IN-1 shows superior potency in multiple MM lines[1].
LSD1/HDAC6-IN-1 is efficacy in the MM.1S xenograft model[1].
[1]. M Naveen Sadhu, et al. Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma. Bioorg Med Chem Lett. 2020 Dec 24;34:127763.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *